GenePeeks has appointed Matt Posard as president and chief commercial officer.
Posard will lead commercialization of the firm's genetic disease risk analysis products.
He most recently led Trovagene's commercial operations as executive VP and CCO. Prior to that, he spent nine years at Illumina, serving in senior marketing, sales, and other commercial roles, as well as time with Alere and Hologic.
Posard sits on the board of directors of several biotech firms such as Slip Chip and Omicia.